Analysts expect Enveric Biosciences, Inc. to report revenue of 0.00 for Q2 24, against a range of 0.00 to 0.00. The most recent reported quarter, Q1 24, came in at 0.00.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | - | - | - | - | - | - | - | - | |||||||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.66 M | |||||||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.47 M | |||||||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.57 M |
Analysts expect Enveric Biosciences, Inc. to report earnings per share of -95.99 for Q3 26, against a range of -101.22 to -90.76. The most recent reported quarter, Q2 26, came in at -0.76, a 99.0% beat against the -75.48 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -109.80 | -41.40 | -43.20 | -57.96 | -14.64 | -11.64 | -10.81 | 0.85 | -1.08 | -0.76 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | -132.70 | -86.07 | -90.22 | -41.08 | -65.29 | -63.26 | -55.23 | -50.55 | -55.84 | -69.89 | -90.76 | -84.34 | -17.51 | -14.00 | -37.99 | -35.31 | -2.89 | 5.36 | ||||||
| Low Estimate | -158.62 | -100.83 | -104.94 | -45.44 | -71.81 | -71.10 | -62.75 | -55.17 | -66.14 | -81.07 | -101.22 | -98.88 | -19.39 | -15.58 | -42.85 | -42.43 | -3.49 | 4.72 | ||||||
| Consensus Estimate | -145.66 | -93.45 | -97.58 | -43.26 | -68.55 | -67.18 | -58.99 | -52.86 | -60.99 | -75.48 | -95.99 | -91.61 | -18.45 | -14.79 | -40.42 | -38.87 | -3.19 | 5.04 |
Pull Wall Street consensus for Enveric Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ENVB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ENVB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ENVB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();